These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 5595437

  • 1. [Action mechanism and clinical success of Regelan (Clofibrate)].
    Fitzgerald JD.
    Wien Klin Wochenschr; 1967 Sep 29; 79(39):716-20. PubMed ID: 5595437
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical-experimental studies on lipid metabolism using Regelan].
    Hammerl H.
    Wien Klin Wochenschr; 1967 Sep 29; 79(39):720-2. PubMed ID: 4875575
    [No Abstract] [Full Text] [Related]

  • 3. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
    Cullen JF, Ireland JT, Oliver MF.
    Trans Ophthalmol Soc U K (1962); 1964 Sep 29; 84():281-95. PubMed ID: 5227423
    [No Abstract] [Full Text] [Related]

  • 4. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun 16; 9(12):45-7. PubMed ID: 6037633
    [No Abstract] [Full Text] [Related]

  • 5. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
    De Gennes JL, Maunand B, Salmon D, Laudat P, Truffert J.
    Rev Atheroscler (Paris); 1966 Jun 16; 8(1):27-52. PubMed ID: 5961027
    [No Abstract] [Full Text] [Related]

  • 6. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
    Vannas S, Esilä R, Tuovinen E.
    Acta Ophthalmol (Copenh); 1968 Jun 16; 46(2):162-70. PubMed ID: 5755673
    [No Abstract] [Full Text] [Related]

  • 7. A three-year trial of atromid therapy in exudative diabetic retinopathy.
    Duncan LJ, Cullen JF, Ireland JT, Nolan J, Clarke BF, Oliver MF.
    Diabetes; 1968 Jul 16; 17(7):458-67. PubMed ID: 4875170
    [No Abstract] [Full Text] [Related]

  • 8. [The therapeutic use of CPIB in pathological increase of the lipid constituents of the blood].
    Cloarec M, Cottet J, Etienne J, Loeper J.
    Sem Ther; 1965 Nov 16; 41(9):499-500. PubMed ID: 5877602
    [No Abstract] [Full Text] [Related]

  • 9. Clofibrate and androsterone effect on serum lipids.
    Orgain ES, Bogdonoff MD, Cain C.
    Arch Intern Med; 1967 Jan 16; 119(1):80-5. PubMed ID: 6015838
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
    Braunsteiner H, Herbst M, Sandhofer F, Sailer S.
    Dtsch Med Wochenschr; 1967 Dec 15; 92(50):2302-8. PubMed ID: 6075896
    [No Abstract] [Full Text] [Related]

  • 12. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
    Rilliet B, Monnier J.
    Praxis; 1969 Jun 24; 58(25):815-20. PubMed ID: 5819485
    [No Abstract] [Full Text] [Related]

  • 13. Effect of clofibrate on low-density lipoprotein turnover in essential hypercholesterolaemia.
    Scott PJ, Hurley PJ.
    J Atheroscler Res; 1969 Jun 24; 9(1):25-34. PubMed ID: 5779579
    [No Abstract] [Full Text] [Related]

  • 14. [Drug therapy of essential hypercholesteremia?].
    Schettler G.
    Dtsch Med Wochenschr; 1968 Sep 13; 93(37):1779. PubMed ID: 5681549
    [No Abstract] [Full Text] [Related]

  • 15. Hypolipidemic agents--newly approved.
    Duncan GG.
    Pa Med; 1967 Aug 13; 70(8):75-6. PubMed ID: 6073724
    [No Abstract] [Full Text] [Related]

  • 16. Divergent effects in the treatment of hyperlipemia.
    Slowe IA, Carter AC, Feldman EB.
    Arch Intern Med; 1965 Oct 13; 116(4):523-30. PubMed ID: 5835355
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
    Warembourg H, Jaillard J.
    Lille Med; 1965 Apr 13; 10(4):431-6. PubMed ID: 5318637
    [No Abstract] [Full Text] [Related]

  • 18. The effect of clofibrate on raised serum lipid levels.
    Smith RB, Prior IA, Cooke NJ.
    N Z Med J; 1968 Oct 13; 68(437):231-4. PubMed ID: 5247681
    [No Abstract] [Full Text] [Related]

  • 19. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L, Rétsági G, Sebestyén M, Diczendy S, Erdélyi G.
    Z Gesamte Inn Med; 1966 Mar 15; 21(6):169-72. PubMed ID: 5988081
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV.
    Ter Arkh; 1968 Mar 15; 40(3):15-20. PubMed ID: 4875984
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.